February 8, 2023

Pharma
February 8, 2023
The Pill Club Reaches $18.3 Million Medicaid Fraud Settlement with California
February 8, 2023
The ADHD Medication Shortage Is Getting Worse. What Went Wrong?
February 7, 2023
‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries
February 7, 2023
The Antibiotic Resistance Crisis Has a Troubling Twist
February 6, 2023
Mark Cuban and Amazon Are Shaking Up Generic Drugs
February 6, 2023
Why a New Alzheimer’s Drug Is Having a Slow US Debut
February 6, 2023
NYC Ending COVID-19 Vaccination Mandate for City Employees
February 3, 2023
The FTC Is Finally Ready to Take on Health Data Leaks. The Problem Is Bigger Than GoodRx
February 3, 2023
Repurposed Drug Battles ‘Brain-Eating’ Amoeba
February 3, 2023
MDMA and Psilocybin Are Approved as Medicines for the First Time
February 2, 2023
A Single-Shot Treatment to Protect Infants from RSV May Be Coming Soon
February 2, 2023
Rare Polio Case Highlights How Hard It Will Be to Keep Polio Gone Once It’s Eradicated
February 2, 2023
African Countries Lack ‘Immediate Access’ to Cholera Vaccine
February 2, 2023
Eye Drops Linked to US Drug-Resistant Bacteria Outbreak
February 2, 2023
The Next Generation of Coronavirus Vaccines: a Graphical Guide
February 2, 2023
Could a Popular COVID-19 Antiviral Supercharge the Pandemic?
February 1, 2023
Vaccine Makers Kept $1.4 Billion in Prepayments for Canceled Covid Shots for the World’s Poor
January 31, 2023
Appeals Court Clears the Way for More Lawsuits over Johnson’s Baby Powder
January 31, 2023
U.S. Appeals Court Sides with Drugmakers on Discount Program
January 31, 2023
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
January 31, 2023
Indonesia Finds Local Trader Forged Ingredient Label in Probe of Cough Syrup Deaths
January 30, 2023
As It Turns 40, the Orphan Drug Act for Rare Diseases Needs a Refresh
January 30, 2023
Covid Vaccines Targeting Omicron Should Be Standard, Panel Says
January 30, 2023